102 related articles for article (PubMed ID: 14687631)
1. In vivo comparison of IVDU and IVFRU in HSV1-TK gene expressing tumor bearing rats.
Choi TH; Ahn SH; Kwon HC; Choi CW; Awh OD; Lim SM
Appl Radiat Isot; 2004 Jan; 60(1):15-21. PubMed ID: 14687631
[TBL] [Abstract][Full Text] [Related]
2. A human osteosarcoma cell line expressing herpes simplex type-1 thymidine kinase: studies with radiolabeled (E)-5-(2-iodovinyl)-2'-fluoro-2'-deoxyuridine.
Morin KW; Duan W; Knaus EE; McEwan AJ; Wiebe LI
Nucl Med Biol; 2005 Jul; 32(5):459-64. PubMed ID: 15982576
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive scintigraphic monitoring of gene expression in a HSV-1 thymidine kinase gene therapy model.
Morin KW; Knaus EE; Wiebe LI
Nucl Med Commun; 1997 Jul; 18(7):599-605. PubMed ID: 9342096
[TBL] [Abstract][Full Text] [Related]
4. Reporter gene imaging: effects of ganciclovir treatment on nucleoside uptake, hypoxia and perfusion in a murine gene therapy tumour model that expresses herpes simplex type-1 thymidine kinase.
Morin KW; Knaus EE; Wiebe LI; Xia H; McEwan AJ
Nucl Med Commun; 2000 Feb; 21(2):129-37. PubMed ID: 10758606
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and cellular uptake of 2'-substituted analogues of (E)-5-(2-[125I]iodovinyl)-2'-deoxyuridine in tumor cells transduced with the herpes simplex type-1 thymidine kinase gene. Evaluation as probes for monitoring gene therapy.
Morin KW; Atrazheva ED; Knaus EE; Wiebe LI
J Med Chem; 1997 Jul; 40(14):2184-90. PubMed ID: 9216837
[TBL] [Abstract][Full Text] [Related]
6. Novel (E)-5-(2-iodovinyl)-2'-deoxyuridine derivatives as potential cytostatic agents against herpes simplex virus thymidine kinase gene transfected tumors.
Balzarini J; Morin KW; Knaus EE; Wiebe LI; De Clercq E
Gene Ther; 1995 Jul; 2(5):317-22. PubMed ID: 7671107
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of sodium/iodide symporter gene as a new imaging reporter gene: comparison with HSV1-tk.
Shin JH; Chung JK; Kang JH; Lee YJ; Kim KI; Kim CW; Jeong JM; Lee DS; Lee MC
Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):425-32. PubMed ID: 14689242
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity and cellular uptake of pyrimidine nucleosides for imaging herpes simplex type-1 thymidine kinase (HSV-1 TK) expression in mammalian cells.
Morin KW; Duan W; Xu L; Zhou A; Moharram S; Knaus EE; McEwan AJ; Wiebe LI
Nucl Med Biol; 2004 Jul; 31(5):623-30. PubMed ID: 15219281
[TBL] [Abstract][Full Text] [Related]
9. In vivo evaluation of the uptake of [(123)I]FIAU, [(123)I]IVFRU and [(123)I]IVFAU by normal mouse brain: potential for noninvasive assessment of HSV-1 thymidine kinase gene expression in gliomas.
Li HF; Winkeler A; Moharram S; Knaus EE; Dittmar K; Stöckle M; Heiss WD; Wiebe LI; Jacobs AH
Nucleosides Nucleotides Nucleic Acids; 2008 Jan; 27(1):57-66. PubMed ID: 18188770
[TBL] [Abstract][Full Text] [Related]
10. Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine derivatives for murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 thymidine kinase gene.
Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Seno T
Mol Pharmacol; 1985 Dec; 28(6):581-7. PubMed ID: 3001499
[TBL] [Abstract][Full Text] [Related]
11. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
[TBL] [Abstract][Full Text] [Related]
12. In vivo imaging of herpes simplex virus type 1 thymidine kinase gene expression: early kinetics of radiolabelled FIAU.
Haubner R; Avril N; Hantzopoulos PA; Gansbacher B; Schwaiger M
Eur J Nucl Med; 2000 Mar; 27(3):283-91. PubMed ID: 10774880
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive in vivo imaging with radiolabelled FIAU for monitoring cancer gene therapy using herpes simplex virus type 1 thymidine kinase and ganciclovir.
Deng WP; Yang WK; Lai WF; Liu RS; Hwang JJ; Yang DM; Fu YK; Wang HE
Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):99-109. PubMed ID: 14513292
[TBL] [Abstract][Full Text] [Related]
14. Quantitative uptake studies of 131I-labeled (E)-5-(2-iodovinyl)-2'-deoxyuridine in herpes simplex virus-infected cells in vitro.
Gill MJ; Samuel J; Wiebe LI; Knaus EE; Tyrrell DL
Antimicrob Agents Chemother; 1984 Apr; 25(4):476-8. PubMed ID: 6732216
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiviral activity of IVFRU, a potential probe for the non-invasive diagnosis of herpes simplex encephalitis.
Iwashina T; Tovell DR; Xu L; Tyrrell DL; Knaus EE; Wiebe LI
Drug Des Deliv; 1988 Dec; 3(4):309-21. PubMed ID: 2855580
[TBL] [Abstract][Full Text] [Related]
16. Comparison of [18F]FHPG and [124/125I]FIAU for imaging herpes simplex virus type 1 thymidine kinase gene expression.
Brust P; Haubner R; Friedrich A; Scheunemann M; Anton M; Koufaki ON; Hauses M; Noll S; Noll B; Haberkorn U; Schackert G; Schackert HK; Avril N; Johannsen B
Eur J Nucl Med; 2001 Jun; 28(6):721-9. PubMed ID: 11440032
[TBL] [Abstract][Full Text] [Related]
17. Differential metabolism of (E)-5-(2-iodovinyl)-2'-deoxyuridine (IVDU) by equine herpesvirus type 1- and herpes simplex virus-infected cells.
Kit S; Ichimura H; De Clercq E
Antiviral Res; 1987 Aug; 8(1):41-51. PubMed ID: 2825591
[TBL] [Abstract][Full Text] [Related]
18. Quantitative kinetics of [124I]FIAU in cat and man.
Jacobs A; Bräunlich I; Graf R; Lercher M; Sakaki T; Voges J; Hesselmann V; Brandau W; Wienhard K; Heiss WD
J Nucl Med; 2001 Mar; 42(3):467-75. PubMed ID: 11337525
[TBL] [Abstract][Full Text] [Related]
19. 5-Fluoro-1-(2'-deoxy-2'-fluoro-beta-D-ribofuranosyl) uracil trapping in Morris hepatoma cells expressing the herpes simplex virus thymidine kinase gene.
Germann C; Shields AF; Grierson JR; Morr I; Haberkorn U
J Nucl Med; 1998 Aug; 39(8):1418-23. PubMed ID: 9708520
[TBL] [Abstract][Full Text] [Related]
20. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP
J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
